News
The collaboration will use AI technology to accelerate the drug discovery process.
The companies will develop a solution based on a new technique of flow cytometry that enables fast and accurate cell analysis using AI.
Users are able to get a list of potential conditions and send their information to their providers.
The new tool lets users send their glucose data to caregivers and clinicians.
Also: Artificial scores $21.5M for lab automation, medication adherence platform emocha Health completes oversubscribed Series A and DeepScribe raises $5.2M in seed funding.
Frugal Innovation
The two college students built Spira, a no-code back-end tool for creating smart intake forms that was acquired by Galileo Health in April.
DarioHealth has made a number of M&As over the last year, boosting its services.
The company upped its revenue expectations for 2021 following the first quarter’s results.
The company is emphasing the importance of its new platform Converge for future business.